日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma

CD147靶向小分子抑制剂通过诱导胰腺导管腺癌中的铁死亡来增强吉西他滨的疗效

期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2025.102292
Jiaqi Li,Chaozhe Ma,Pei Cao,Weihua Guo,Pengyu Wang,Yang Yang,Bowen Ding,Fengyi Yin,Zhe Li,Yifei Wang,Shouyi Li,Chongbiao Huang,Xiuchao Wang,Tianxing Zhou,Antao Chang,Liang Zhao,Song Gao,Tiansuo Zhao,Hongwei Wang,Jun Yu,Jingyuan Xu,Yukuan Feng,Jihui Hao
胰腺癌
肿瘤
CD14
CD147
铁死亡
发表日期：2025
文献求助 收藏

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

厄贝沙坦通过抑制 Hippo/YAP1/c-Jun 轴来抑制干细胞和铁代谢，从而克服胰腺癌对吉西他滨的耐药性

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-023-02671-8
Tianxing Zhou #, Yongjie Xie #, Xupeng Hou #, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan, Zhaoyu Zhang, Yifei Wang, Hongwei Wang, Wenna Jiang, Song Gao, Tiansuo Zhao, Antao Chang, Xiuchao Wang, Hongxia Sun, Xiufeng Zhang, Shengyu Yang, Chongbiao Huang, Jihui Hao,
代谢
信号转导
发育与干细胞
肿瘤
胰腺癌
干细胞
Hippo
发表日期：2023
文献求助 收藏

Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma

核 PLD1 与 NPM1 结合通过致瘤 IL7R 诱导胰腺腺癌产生吉西他滨耐药性

期刊:Cancer Biology & Medicine
影响因子:5.6
doi:10.20892/j.issn.2095-3941.2023.0039
Danqi Fu #, Jingrui Yan #, Zhaoyu Zhang #, Yang Liu, Xiaoqing Ma, Jinsheng Ding, Shengyu Yang, Ran Zhao, Antao Chang, Chuntao Gao, Jing Liu, Tiansuo Zhao, Xiuchao Wang, Chongbiao Huang, Song Gao, Ying Ma, Bo Tang, Yukuan Feng, Hongwei Wang, Jihui Hao
代谢
肿瘤
胰腺癌
发表日期：2023
文献求助 收藏

ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis

ESE3 阳性 PSC 通过肿瘤基质 IL-1β/NF-κB/ESE3 信号轴驱动胰腺癌纤维化、化学耐药性和不良预后

期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/s41416-022-01927-y
Tiansuo Zhao #, Di Xiao #, Fanjie Jin #, Xugang Sun, Jie Yu, Hongwei Wang, Jing Liu, Wenrun Cai, Chongbiao Huang, Xiuchao Wang, Song Gao, Zhe Liu, Shengyu Yang, Chuntao Gao, Jihui Hao
代谢
信号转导
肿瘤
胰腺癌
NF-κB
发表日期：2022
文献求助 收藏

An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers

综合泛癌症分析显示 MLN4924 (Pevonedistat) 是 YAP 驱动癌症中靶向 Skp2 的潜在治疗药物

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2022.866702
Chungen Lan, Bo Ni, Tiansuo Zhao, Zekun Li, Junjin Wang, Ying Ma, Weidong Li, Xiuchao Wang
肿瘤
发表日期：2022
文献求助 收藏

Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting

血清胰岛素样生长因子结合蛋白 2 水平作为胰腺导管腺癌相关营养不良和肌肉萎缩的生物标志物

期刊:Journal of Cachexia Sarcopenia and Muscle
影响因子:9.4
doi:10.1002/jcsm.12692
Jie Dong, Jie Yu, Zekun Li, Song Gao, Hongwei Wang, Shengyu Yang, Liangliang Wu, Chungen Lan, Tiansuo Zhao, Chuntao Gao, Zhe Liu, Xiuchao Wang, Jihui Hao
代谢
肿瘤
胰腺癌
发表日期：2021
文献求助 收藏

PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer

PERK-eIF2α-ERK1/2 轴驱动胰腺癌相关成纤维细胞的间充质-内皮转化

期刊:Cancer Letters
影响因子:9.1
doi:10.1016/j.canlet.2021.05.021
Wenrun Cai, Xugang Sun, Fanjie Jin, Di Xiao, Hui Li, Huizhi Sun, Yifei Wang, Yang Lu, Jing Liu, Chongbiao Huang, Xiuchao Wang, Song Gao, Hongwei Wang, Chuntao Gao, Tiansuo Zhao, Jihui Hao
代谢
信号转导
肿瘤
胰腺癌
成纤维细胞
MAPK/ERK
发表日期：2021
文献求助 收藏

IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer

IL-37/STAT3/HIF-1α 负反馈信号驱动胰腺癌产生吉西他滨耐药性

期刊:Theranostics
影响因子:12.4
doi:10.7150/thno.42416
Tiansuo Zhao, Fanjie Jin, Di Xiao, Hongwei Wang, Chongbiao Huang, Xiuchao Wang, Song Gao, Jing Liu, Shengyu Yang, Jihui Hao
代谢
信号转导
肿瘤
胰腺癌
发表日期：2020
文献求助 收藏

Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression

蛋白酶体抑制剂 MG132 通过增加 ESE3 表达来抑制胰腺导管腺癌细胞迁移

期刊:Oncology Letters
影响因子:2.5
doi:10.3892/ol.2019.11157
Fanjie Jin, Di Xiao, Tiansuo Zhao, Ming Yu
代谢
肿瘤
胰腺癌
肿瘤细胞
发表日期：2020
文献求助 收藏

Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma

肿瘤内皮生长因子（EHF）可预测抗PD-1疗法在胰腺导管腺癌中的疗效

期刊:Journal of Experimental Medicine
影响因子:12.6
doi:10.1084/jem.20180749
Jing Liu ，Wenna Jiang ，Kaili Zhao ，Hongwei Wang ，Tianxing Zhou ，Weiwei Bai ，Xiuchao Wang ，Tiansuo Zhao ，Chongbiao Huang ，Song Gao ，Tai Qin ，Wenwen Yu ，Bo Yang ，Xin Li ，Danqi Fu ，Wei Tan ，Shengyu Yang ，He Ren ，Jihui Hao
PD-1
肿瘤免疫
肿瘤
发表日期：2019
文献求助 收藏